SOAT2 and fatty liver disease: Researchers now understand that SOAT has two isozymes, SOAT1 and SOAT2, with distinct functions in the human body [2,3,4,5], and that selective inhibition of SOAT2 is responsible for the prevention of atherosclerosis and fatty liver disease [6,7,8,9,10].